Your browser doesn't support javascript.
loading
MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang, Shu; Yuan, Yixiao; Ren, Wenjun; Wang, Haiyu; Zhao, Zhong; Zhao, Heng; Zhao, Qizhe; Chen, Xi; Jiang, Xiulin; Zhang, Lei.
Afiliación
  • Yang S; Department of Neurology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
  • Yuan Y; Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Ren W; Department of Cardiovascular Surgery, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
  • Wang H; Department of Cardiovascular Surgery, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
  • Zhao Z; Department of Neurology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
  • Zhao H; Department of Neurosurgery, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
  • Zhao Q; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Chen X; First Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Jiang X; Kunming College of Life Science, University of Chinese Academy of Sciences, Beijing, China.
  • Zhang L; Department of Neurology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
Front Oncol ; 12: 1004324, 2022.
Article en En | MEDLINE | ID: mdl-36465369

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza